You’re in control with flexible, data-driven drug product services.
The expertise to address today's development challenges.
Achieve your molecule’s next milestone with fit-for-phase drug product formulations, backed by trusted data and the insight you need to navigate the increasing complexity of small molecule and synthetic peptide therapeutics.
Quotient Sciences streamlines the transitions between each stage of development to help you bring your drug product to market quickly, with no compromises to safety or quality.

- Bridge the Gaps
Our focus is always phase-appropriate. That means we personalize support for your drug program today while looking ahead to future milestones.
- Adapt Rapidly
Bring high-quality drug products to market faster with confidence. By anticipating challenges, we help you adapt and stay in control as you scale up from registration to process validation, NDA filing, and commercial launch.
- Maximize Efficiency
Our teams across the UK and US utilize a range of technologies alongside proven strategies for navigating development in the most efficient way possible.
Quotient Sciences emphasizes the importance of data-driven decisions in early development. Our scientific experts prioritize key API characterization data to recommend the appropriate API form and inform a strategy for preclinical and clinical pharmaceutical development based on the Developability Classification System (DCS).
We anticipate clinical considerations and perform early-laboratory prototyping to de-risk process scale-up and development once a molecule achieves its early clinical endpoints.
We offer a full spectrum of manufacturing and supply paradigms, from traditional large batch manufacturing to bright stock distribution and personalized manufacturing. In addition, our ability to produce small batch sizes facilitates conservation of API and dose flexibility. Fundamentally, personalized manufacturing means the product is made on-demand—only when needed and based on patient requirements.
We have extensive experience in both traditional formulation development and Translational Pharmaceutics, which combines our drug product and clinical capabilities into a bespoke program that enables formulation decisions based on emerging human data.
We’ve applied formulation flexibility in healthy volunteer trials to a number of applications and therapeutic areas, including oncology where volunteer studies have been conducted to inform “patient ready” formulations in less than half the time of the industry standard.
We recognize the need to move rapidly and efficiently through clinical development. So we ensure a seamless transition to larger-scale manufacturing and drug product commercialization by leveraging our expertise to scale up manufacturing processes from Phase I to meet the demands of later clinical trials.
Quotient Sciences' robust manufacturing and supply chain allows for seamless continuity throughout the development life cycle. We have experience with accelerated approval pathways to guide development programs through registration and process validation, and can support batch sizes ranging from less than 1 kg to over 500 kg for solid oral dosage forms.
We have the expertise and regulatory approval to manufacture your registration and validation batches for the U.S., U.K., Europe, Japan, China, and other global filing markets. Additionally, our experience extends to supporting 505(b)(2) and all post-approval change filings.
Quotient Sciences Drug Product Development & Manufacturing Services
Achieve your molecule’s potential with our extensive experience in designing drug product formulations.

Over 30 years
experience in drug product formulation development and manufacturing.

Scalable batch sizes
ranging small batch sizes to support clinical trial materials, to over 500 kg for solid oral dosage forms in commercial drug product. We can also support the development of parenteral dosage forms, topical dosage forms (gels, ointments, and creams), and oral liquids.

Trusted by leading companies
including Fortune 100 large pharmaceutical companies and emerging biotechs.
Meet Our Drug Product Experts
Dr. Asma Patel
VP, Integrated Development Services
Dr. Asma Patel is responsible for providing scientific and technical support to Quotient Sciences' business development group and ...
About AsmaJamie Weishaar
VP, Global Commercial Drug Product
Jamie Weishaar is an experienced business development executive leader specializing in pharmaceutical drug development, including ...
About JamieAmit Patel
Senior Director of Technical Services
Amit Patel, Senior Director of Technical Services, has held various technical and operational leadership roles during his 15-year ...
About AmitRobert Cornog
Senior Director, Product Development
Robert Cornog has over 26 years of experience in product development and process design, across a broad range of dosage forms and ...
About RobertQuotient Sciences has multiple U.S. facilities where drug product manufacturing and clinical pharmacology are performed, as well as US-based business development and scientific teams. Quotient Sciences U.S. facilities are located in Boothwyn and Garnet Valley, Pennsylvania (both near Philadelphia in Eastern Pennsylvania) as well as in Miami, Florida.
From facilities located in the US and UK, Quotient Sciences offers coordinated contract research, development, and manufacturing services (CRO services and CDMO services) as part of one organization. Drug product manufacturing is performed at facilities in Nottingham and Reading, UK, and in the US from our two facilities located near Philadelphia, PA.
Good Manufacturing Practices (GMP) refer to the guidelines that ensure that pharmaceutical products are produced in a consistent way, maintaining quality standards. Also known as current Good Manufacturing Practices, or cGMP, these practices focus on ensuring safety, quality, and efficacy of drug products over the lifecycle of a drug. Quotient Sciences adheres to cGMP practices at all of our global pharma manufacturing facilities.
A CRDMO is a contract research, development, and manufacturing organization. A company that offers CRDMO services integrates different areas that would typically be found by selecting multiple vendors.